Equifax, Inc. (NYSE:EFX)‘s stock had its “equal weight” rating reaffirmed by equities research analysts at Stephens in a research report issued to clients and investors on Wednesday. They presently have a $110.00 price objective on the credit services provider’s stock. Stephens’ price target points to a potential downside of 1.72% from the stock’s current price.

Other analysts have also issued reports about the stock. Cowen and Company reissued a “buy” rating and set a $151.00 target price on shares of Equifax in a research note on Friday, July 28th. Morgan Stanley reaffirmed an “equal weight” rating and issued a $144.00 price target (up previously from $142.00) on shares of Equifax in a research note on Tuesday, July 18th. Stifel Nicolaus reaffirmed a “buy” rating and issued a $149.00 price target on shares of Equifax in a research note on Friday, September 8th. Zacks Investment Research lowered shares of Equifax from a “buy” rating to a “hold” rating in a report on Monday, July 17th. Finally, BidaskClub lowered shares of Equifax from a “buy” rating to a “hold” rating in a report on Tuesday, June 27th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and eleven have assigned a buy rating to the company’s stock. Equifax presently has an average rating of “Buy” and a consensus target price of $130.50.

Shares of Equifax (NYSE:EFX) traded up 1.34% during mid-day trading on Wednesday, reaching $111.93. 3,973,804 shares of the company’s stock traded hands. The stock has a 50-day moving average price of $122.29 and a 200 day moving average price of $134.47. Equifax has a 12-month low of $89.59 and a 12-month high of $147.02. The firm has a market capitalization of $13.47 billion, a price-to-earnings ratio of 23.71 and a beta of 0.87.

Equifax (NYSE:EFX) last announced its quarterly earnings data on Wednesday, July 26th. The credit services provider reported $1.60 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.57 by $0.03. The company had revenue of $856.70 million for the quarter, compared to the consensus estimate of $860.48 million. Equifax had a return on equity of 24.88% and a net margin of 17.44%. Equifax’s quarterly revenue was up 5.6% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.43 EPS. Analysts anticipate that Equifax will post $5.98 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Equifax, Inc. (EFX) Earns “Equal Weight” Rating from Stephens” was originally reported by American Banking News and is the property of of American Banking News. If you are accessing this piece on another publication, it was illegally copied and republished in violation of U.S. & international trademark and copyright laws. The original version of this piece can be viewed at https://www.americanbankingnews.com/2017/10/04/equifax-inc-efx-earns-equal-weight-rating-from-stephens.html.

In related news, insider Joseph Michael Loughran III sold 4,000 shares of the stock in a transaction that occurred on Tuesday, August 1st. The shares were sold at an average price of $146.02, for a total transaction of $584,080.00. Following the completion of the sale, the insider now owns 42,723 shares of the company’s stock, valued at $6,238,412.46. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Rodolfo O. Ploder sold 1,719 shares of the firm’s stock in a transaction that occurred on Wednesday, August 2nd. The shares were sold at an average price of $145.70, for a total transaction of $250,458.30. Following the completion of the sale, the insider now owns 43,648 shares of the company’s stock, valued at $6,359,513.60. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 12,219 shares of company stock worth $1,780,938. 1.29% of the stock is owned by corporate insiders.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. UBS Asset Management Americas Inc. lifted its holdings in shares of Equifax by 41.4% during the 1st quarter. UBS Asset Management Americas Inc. now owns 404,023 shares of the credit services provider’s stock valued at $55,246,000 after purchasing an additional 118,212 shares during the last quarter. Raymond James Financial Services Advisors Inc. boosted its position in shares of Equifax by 33.9% in the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 3,771 shares of the credit services provider’s stock worth $516,000 after purchasing an additional 955 shares in the last quarter. Pacer Advisors Inc. boosted its position in shares of Equifax by 3.5% in the 1st quarter. Pacer Advisors Inc. now owns 2,300 shares of the credit services provider’s stock worth $315,000 after purchasing an additional 77 shares in the last quarter. Victory Capital Management Inc. boosted its position in shares of Equifax by 28.7% in the 1st quarter. Victory Capital Management Inc. now owns 13,250 shares of the credit services provider’s stock worth $1,812,000 after purchasing an additional 2,957 shares in the last quarter. Finally, Cibc World Markets Corp boosted its position in shares of Equifax by 53.3% in the 1st quarter. Cibc World Markets Corp now owns 12,535 shares of the credit services provider’s stock worth $1,714,000 after purchasing an additional 4,357 shares in the last quarter. 90.00% of the stock is currently owned by institutional investors and hedge funds.

About Equifax

Equifax Inc is a global provider of information solutions and human resources business process outsourcing services for businesses, governments and consumers. The Company operates in four segments: U.S. Information Solutions (USIS), International, Workforce Solutions and Global Consumer Solutions. Its products and services are based on databases of consumer and business information derived from various sources, including credit, financial assets, telecommunications and utility payments, employment, income, demographic and marketing data.

Analyst Recommendations for Equifax (NYSE:EFX)

Receive News & Ratings for Equifax Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equifax Inc. and related companies with MarketBeat.com's FREE daily email newsletter.